ANI Pharmaceuticals
ANIP
#5426
Rank
A$2.23 B
Marketcap
A$98.23
Share price
0.76%
Change (1 day)
-28.22%
Change (1 year)

P/S ratio for ANI Pharmaceuticals (ANIP)

P/S ratio as of November 2026 (TTM): 1.58

According to ANI Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.59. At the end of 2023 the company had a P/S ratio of 2.31.

P/S ratio history for ANI Pharmaceuticals from 2001 to 2023

PS ratio at the end of each year

Year P/S ratio Change
20232.314.25%
20222.22-37.55%
20213.55106.33%
20201.72-52.33%
20193.6136.37%
20182.65-37.62%
20174.25-22.25%
20165.46-19.72%
20156.80-40.75%
201411.546.48%
20137.84-40.11%
201213.1-89.69%
2011127134.16%
201054.2-12.34%
200961.8748.33%
20087.29-96.5%
20072084549.39%
20064.48-98.36%
2005274-79.87%
2004> 10004366.23%
200330.5383.09%
20026.31-78.89%
200129.9

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Novartis
NVS
5.39 240.31%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
2.64 66.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
0.2490-84.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
3.38 113.69%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Evoke Pharma
EVOK
1.31-17.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
> 1000 990,240.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
2.89 82.44%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Royalty Pharma
RPRX
15.6 883.96%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lannett Company
LCI
0.0238-98.50%๐Ÿ‡บ๐Ÿ‡ธ USA